Likewise, we demonstrated that c-MET inhibitors could not effectively block NF-κB induction by Gefitinib in FaDu cells, although others reported that c-MET regulated EGFR inhibitor resistance through NF-κB in lung cancer (ref. 35, Supplementary Figure 9). Here, MET is linked to lung cancer.